Drug profile · INN
baricitinib
OLUMIANT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
baricitinib (OLUMIANT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN baricitinib
Brand OLUMIANT
Route ORAL
Formulation TABLET
ATC code L04AA37
Frequently asked questions
What is baricitinib?
baricitinib (OLUMIANT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for baricitinib?
OLUMIANT is a marketed brand name for baricitinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of baricitinib?
baricitinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.